Medical AIPercent total body weight loss (%TBWL) calculator
Percent total body weight loss expresses change in weight as a fraction of starting weight. It is the standard way to monitor and report response to obesity treatment, including GLP-1 and dual incretin therapies. A loss of 5% or more is generally considered clinically meaningful, with greater benefit at 10% and 15% or more. It is a monitoring metric, not a diagnosis.
How to measure each input
- Baseline weight
- Use a consistent, documented starting weight, ideally the weight at treatment initiation, measured on the same scale and under similar conditions as follow-up.
- Current weight
- Measure under comparable conditions (similar time of day, clothing, and hydration). Enter in the same unit as baseline; the percentage is unit-independent.
- Timing
- Response is usually assessed after the patient has reached and maintained the target therapeutic dose for an adequate period, not during dose escalation.
Interpretation
| Band | Meaning |
|---|---|
| Weight gain | Current weight exceeds baseline. Review adherence, dose, diet and activity, and concurrent medications that can promote weight gain. |
| Less than 5% loss | Below the usual threshold for a clinically meaningful response. For pharmacotherapy, many guidelines suggest reassessing or escalating if a meaningful loss is not reached after an adequate trial at the target dose. |
| 5 to 9.9% loss (clinically meaningful) | A loss of 5% or more is generally considered clinically meaningful and is enough to improve several weight-related complications (glycaemia, blood pressure, lipids). |
| 10 to 14.9% loss | Greater benefit across many complication-specific targets. The AACE/ACE guideline recommends at least 10% loss for several of these goals. |
| >= 15% loss | Substantial loss, in the range achieved by higher-efficacy therapies in trials such as STEP (semaglutide) and SURMOUNT (tirzepatide). Associated with broad cardiometabolic improvement; monitor for nutritional adequacy and lean-mass loss. |
Pitfalls, exclusions and caveats
- %TBWL is a monitoring metric, not a diagnosis. It tracks change over time and does not by itself classify obesity (use BMI and clinical assessment for that).
- It depends entirely on an accurate, consistent baseline. A baseline taken on a different scale, at a different time of day, or after fluid shifts will distort the result.
- Rapid weight change can reflect fluid (oedema, dehydration, diuretics) rather than fat. Interpret short-interval changes with caution.
- Trial percentages (for example the mean losses reported in STEP and SURMOUNT) are study-level averages under protocol conditions and will not be matched by every individual in routine care.
- Significant weight loss can include lean mass. Pair monitoring with attention to protein intake, resistance activity, and, where relevant, body composition.
%TBWL = (baseline weight - current weight) / baseline weight x 100. Use the same units for both weights. Obesity-medicine response thresholds: >= 5% clinically meaningful, >= 10% and >= 15% increasingly beneficial.Frequently asked
What counts as a good response to a weight-loss medication?
A total body weight loss of 5% or more is the usual threshold for a clinically meaningful response, and the AACE/ACE guideline recommends targeting at least 10% for many complication-specific goals. Higher-efficacy therapies in trials such as STEP and SURMOUNT achieved mean losses of around 15% and more.
Should I use my lowest-ever weight or my weight when I started treatment?
Use the weight at treatment initiation as the baseline if you are monitoring a specific therapy. The metric is only as meaningful as its baseline, so document and reuse the same starting point and the same scale.
Is %TBWL the same as BMI?
No. BMI classifies weight relative to height at a single point in time; %TBWL measures change relative to a starting weight. They answer different questions and are best used together.
A score is a start. The product is asked.
Calculators give a number. When the patient in front of you needs the reasoning behind it, with the sources, the product is what does the looking-up.
Medical AI returns evidence-grounded answers backed by real citations. It is a reference tool, and these terms describe how it should and should not be used.
01 Educational purpose
Medical AI is an information and reference tool intended for educational use only. The answers it returns are not medical advice, diagnosis, or treatment. Always consult a qualified doctor or healthcare professional with any question concerning a medical condition.
02 Professional use
Medical AI is designed for use by practicing clinicians. It is not intended for direct patient use and is not a substitute for professional clinical judgment. Apply your own training and current guidelines to every decision an answer informs.
03 Privacy and data
We do not collect, store, or process personally identifiable patient information (PHI or PII). Do not enter names, dates of birth, medical record numbers, or any other patient identifiers into the composer.
04 Information currency
Medical knowledge evolves rapidly. Citations carry their publication date, so consult the primary source and the most recent clinical guideline before acting on anything material.